Live News • Aug 19
Trulieve Cannabis Rings NYSE Closing Bell as First US Cannabis Company Listed Trulieve Cannabis has begun trading on the New York Stock Exchange and will ring the Closing Bell to mark its listing, becoming the first U.S. cannabis company on the NYSE, with operations spanning 207 medical dispensaries and 3.5 million square feet of cultivation and production capacity across four states.
The NYSE listing gives Trulieve Cannabis access to one of the largest equity markets in the world, which can widen its institutional investor base and improve liquidity compared with trading on smaller or over-the-counter venues.
Trulieve Cannabis shares trade at $9.69, with the stock up 21.3% over the past 90 days, which places the NYSE debut against a backdrop of recent positive share price momentum.
This step onto the NYSE puts Trulieve Cannabis under greater scrutiny but also in front of a broader pool of capital. The key risk for investors is whether the company can match that higher profile with consistent execution under tighter market and regulatory visibility. Breakeven Date Change • Aug 10
Forecast breakeven date pushed back to 2027 The 7 analysts covering Trulieve Cannabis previously expected the company to break even in 2026. New consensus forecast suggests the company will make a profit of US$94.0m in 2027. Average annual earnings growth of 125% is required to achieve expected profit on schedule. Reported Earnings • Aug 09
Second quarter 2026 earnings: EPS misses analyst expectations Second quarter 2026 results: US$2.10 loss per share (further deteriorated from US$0.071 loss in 2Q 2025). Revenue: US$271.0m (down 10% from 2Q 2025). Net loss: US$405.3m (loss widened US$391.8m from 2Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is expected to decline by 5.7% p.a. on average during the next 3 years, while revenues in the Pharmaceuticals industry in the US are expected to grow by 9.2%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Live News • Aug 08
Trulieve Advances DEA Filings and Expands Georgia Medical Cannabis Distribution Trulieve Cannabis reported Q2 2026 results that included completion of the deconsolidation of Harvest mixed medical and adult use state operations, DEA registration filings for its state licensed medical marijuana businesses after federal rescheduling to Schedule III, the launch of a share repurchase program, and expanded shipments of medical cannabis products to licensed independent pharmacies in Georgia.
These steps alter Trulieve’s operating footprint and legal structure, while the DEA applications and Georgia pharmacy distribution show the company working within shifting federal rules and widening its medical access channels.
Trulieve Cannabis shares trade at $8.75, with the stock down 2.8% on the day.
The mix of regulatory filings, structural changes to Harvest operations and a new buyback program presents several moving parts to watch, particularly around how Trulieve balances compliance, capital allocation and growth in its medical-focused channels. Announcement • Jul 10
Trulieve Cannabis Corp. to Report Q2, 2026 Results on Aug 07, 2026 Trulieve Cannabis Corp. announced that they will report Q2, 2026 results Pre-Market on Aug 07, 2026 Announcement • Jul 03
Trulieve Cannabis Corp. Announces Change of Chief Accounting Officer, Effective June 30, 2026 As of June 30, 2026, Trulieve Cannabis Corp. eliminated the stand-alone position of Chief Accounting Officer. In connection with this action, the Company terminated the employment of Mr. Brett Walsh, who has served as the Company’s Chief Accounting Officer (principal accounting officer), without cause. In connection with the elimination of the stand-alone position of Chief Accounting Officer, the Company appointed Jan Reese, the Company’s Chief Financial Officer (principal financial officer), as the Company’s principal accounting officer, effective June 30, 2026. Mr. Reese will not receive any adjustment to his compensation or any additional compensation in connection with performing the functions of the Company’s principal accounting officer. Live News • Jul 02
Trulieve Launches First Medical Cannabis Flower Sales Across Georgia After New Legislation Trulieve Cannabis marked the expansion of Georgia’s medical cannabis program with a ceremonial first sale of medical cannabis flower at its Marietta dispensary, timed with the implementation of Senate Bill 220 (“Putting Georgia’s Patients First Act”). The company is rolling out new flower and vaporization products across all six of its Georgia locations and distributing to more than a dozen licensed independent pharmacies statewide.
The new law broadens qualifying conditions to include illnesses such as lupus, HIV and inflammatory bowel disease, removes prior limits on conditions like cancer and Parkinson’s disease, and allows patients aged 21 and older to access the newly permitted product forms, widening the potential patient pool for Trulieve in the state.
Trulieve Cannabis shares trade at US$9.54, with the stock up 57.9% over the past 90 days, putting attention on how regulatory shifts in Georgia and at the federal level may influence the company’s U.S. medical footprint.
Taken together, the regulatory expansion in Georgia and Trulieve’s wider product and pharmacy distribution give the company a larger addressable market in a tightly regulated state, but investors still need to weigh how efficiently Trulieve can convert this new access into sustainable revenue given ongoing licensing, compliance and competitive pressures in U.S. medical cannabis. Live News • Jun 28
Trulieve Cannabis Wins NYSE Approval as CEO Nets $1.2 Million in Sale Trulieve Cannabis CEO and Chair Kim Rivers sold 136,811 shares on 26 June 2026 for roughly US$1.2 million, while still retaining significant voting power through indirect ownership.
The company has become the first U.S. cannabis business approved to list on the New York Stock Exchange following the move of medical marijuana to Schedule III, a regulatory step that could broaden its access to institutional investors and deepen trading liquidity.
Trulieve Cannabis shares trade at US$8.99, with the stock up 77.3% over the past 90 days, indicating a sharp recent re-rating by the market.
The combination of insider selling and a high-profile NYSE listing presents mixed signals: liquidity and visibility are improving, while leadership is also taking some cash off the table, which adds an extra layer for you to weigh when judging risk and sentiment. Recent Insider Transactions Derivative • Jun 17
Founder notifies of intention to sell stock Kimberly Rivers intends to sell 2m shares in the next 90 days after lodging an Intent To Sell Form on the 17th of June. If the sale is conducted around the recent share price of US$10.50, it would amount to US$18m. For the year to December 2019, Kimberly's total compensation was 11% salary and 89% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since September 2025, Kimberly's direct individual holding has decreased from 18.66m shares to 274.71k. There has only been one transaction (US$491b purchase) from insiders over the last 12 months. Live News • Jun 16
Trulieve Cannabis Stock Debuts on NYSE After Restructuring and Medical Expansion Plans Trulieve Cannabis became the first U.S. cannabis company to list on the New York Stock Exchange after a corporate restructuring.
The company separated its federally compliant medical cannabis operations from its adult-use business to meet NYSE requirements.
Trulieve’s medical platform now includes 206 DEA-registered dispensaries with substantial cultivation and production capacity and stated plans to enter Texas.
The NYSE listing gives Trulieve Cannabis access to a major U.S. exchange, which can broaden the potential investor base and improve trading visibility compared with over-the-counter listings.
Investors may want to monitor how the separated medical and adult-use operations influence Trulieve’s cost structure, access to capital and regulatory risk profile over time. Announcement • Jun 13
Jason Pernell to Terminate Employment His Position of President of Trulieve Cannabis Corp., Effective June 11, 2026 On June 11, 2026 (the “Termination Date”), the Trulieve Cannabis Corp. and Jason Pernell mutually agreed that Mr. Pernell shall terminate his employment his position of President of Trulieve Cannabis Corp. (the “Company”) effective June 11, 2026. Board Change • Jun 11
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Independent Director Matthew Foulston was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Jun 09
Trulieve Cannabis Corp. (CNSX:TRUL) announces an Equity Buyback for 8,495,038 shares, representing 5% for $50 million. Trulieve Cannabis Corp. (CNSX:TRUL) announces a share repurchase program. Under the program, the company will repurchase up to the lesser of $50 million and 8,495,038 subordinate voting shares of the Company, representing 5% of the Company’s issued and outstanding subordinate voting shares. The shares repurchased will be cancelled. The program will expire on June 16, 2027. Announcement • May 02
Trulieve Cannabis Corp Files Applications with Drug Enforcement Administration for Registration of State Licensed Medical Marijuana Businesses Trulieve Cannabis Corp. had filed applications with the Drug Enforcement Administration to register certain state-licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act. Following the reclassification of medical marijuana to Schedule III, the Drug Enforcement Administration established an expedited registration process for eligible state-licensed medical marijuana operators. For operators that apply within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana products is deemed approved unless otherwise notified. Announcement • Apr 17
Trulieve Cannabis Corp. to Report Q1, 2026 Results on May 07, 2026 Trulieve Cannabis Corp. announced that they will report Q1, 2026 results at 9:30 AM, US Eastern Standard Time on May 07, 2026 Announcement • Apr 01
Trulieve Cannabis Corp., Annual General Meeting, Jun 09, 2026 Trulieve Cannabis Corp., Annual General Meeting, Jun 09, 2026. Announcement • Feb 10
Trulieve Cannabis Corp. to Report Q4, 2025 Results on Feb 26, 2026 Trulieve Cannabis Corp. announced that they will report Q4, 2025 results Pre-Market on Feb 26, 2026 Announcement • Feb 07
Trulieve Cannabis Corp. announced that it has received $13.5 million in funding On February 6, 2026, Trulieve Cannabis Corp. closed the transaction. The transaction included participation from 11 investors. Announcement • Dec 30
Trulieve Cannabis Corp. announced that it has received $51.9 million in funding On December 29, 2025, Trulieve Cannabis Corp. closed the transaction. The transaction included participation from 18 investors. Announcement • Dec 17
Trulieve Cannabis Corp. announced that it has received $140 million in funding On December 17, 2025, Trulieve Cannabis Corp. closed the transaction. The company amended the terms of the transaction. The company received $140 million in the transaction. The notes may be redeemed in whole or in part, at any time from time to time, on or after December 17, 2027 at the applicable redemption price set forth in the second supplemental indenture governing the notes. The notes are subject to a hold period of four months. Announcement • Dec 09
Trulieve Cannabis Corp. announced that it expects to receive $100 million in funding Trulieve Cannabis Corp. announced that it has announced a private placement on best-efforts of Senior Secured Notes for aggregate gross proceeds of $100 million on December 8, 2025. The Notes, which will be issued at 100% of face value, will be senior secured obligations of the Company. The Notes will bear interest at a rate of 10.5% per annum, payable semi-annually in equal installments until the maturity date, unless earlier redeemed or repurchased. The Notes will mature on or about December 17, 2030, and may be redeemed in whole or in part, at any time from time to time, on or after the date that is two years following the issue date at the applicable redemption price set forth in the supplemental indenture to be entered into on closing of the Offering. The transaction is expected to close on December 17, 2025, subject to customary closing conditions, including approval of the Canadian Securities Exchange. The Company intends to make the required filings to list. The notes to be issued pursuant to the Offering on the CSE following the expiry of the four-month Canadian statutory hold period. Announcement • Dec 05
Headline: Trulieve Cannabis Corp Announces Conditional Approval for Texas Dispensing Organization License from Texas Department of Public Safety Trulieve Cannabis Corp. announced the Texas Department of Public Safety granted Trulieve TX Inc. conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. As a licensed Dispensing Organization, Trulieve will cultivate, manufacture, and distribute high quality medical cannabis products to Texas patients. The license is subject to final approval by the Texas Department of Public Safety. Announcement • Oct 15
Trulieve Cannabis Corp. to Report Q3, 2025 Results on Nov 05, 2025 Trulieve Cannabis Corp. announced that they will report Q3, 2025 results on Nov 05, 2025 Announcement • Jul 23
Trulieve Cannabis Corp. Announces Expanded Distribution of Onward and Launch of THC-Infused Energy Drink Upward Trulieve Cannabis Corp. announced expanded distribution of premium Onward beverages and the launch of Upward, a premium THC-infused energy drink. Onward and Upward Farm Bill-compliant beverages are available online and at retail locations in Florida and Illinois. Onward and Upward beverages are available at all ABC Fine Wine & Spirits and Total Wine & More locations in Florida. The company recently entered into new distribution partnerships with Romano Beverage covering Illinois and Anheuser-Busch covering Northern Florida. With these new and expanded arrangements, Onward and Upward beverages can be found at hundreds of stores in Florida and Illinois. New premium Upward beverages come in a variety of delicious flavors including 5 milligram Lemonade, Peach Nectarine, and Strawberry Tea and 10 milligram Pink Lemonade. These low-calorie energy drinks are crafted in the USA using the harmonious balance of THC and CBD found in Onward, plus a boost of energy derived from green coffee beans and black tea leaves. Announcement • Jul 11
Trulieve Partners with Redemption Cannabis to Launch Purpose Led Products in West Virginia Trulieve Cannabis Corp. announced the launch of Redemption Cannabis products at Trulieve dispensaries in West Virginia. Redemption Cannabis, founded by industry advocate Ryan Basore, reinvests a portion of every sale to support individuals and families impacted by cannabis prohibition laws. Redemption's mission stems from Basore's commitment to justice after he served time in federal prison on cannabis-related charges. Redemption's flower will be available in Trulieve dispensaries throughout West Virginia starting July 11. Announcement • Jul 09
Trulieve Cannabis Corp. to Report Q2, 2025 Results on Aug 06, 2025 Trulieve Cannabis Corp. announced that they will report Q2, 2025 results on Aug 06, 2025 Announcement • Apr 10
Trulieve Cannabis Corp. to Report Q1, 2025 Results on May 07, 2025 Trulieve Cannabis Corp. announced that they will report Q1, 2025 results on May 07, 2025 Announcement • Mar 25
Trulieve Cannabis Corp., Annual General Meeting, Jun 12, 2025 Trulieve Cannabis Corp., Annual General Meeting, Jun 12, 2025. Announcement • Mar 08
Trulieve Cannabis Corp. Announces Chief Financial Officer Changes Trulieve Cannabis Corp. announced the appointment of Ryan Blust, the Company's Vice President, Finance, as its interim Chief Financial Officer and the departure of Wes Getman as Chief Financial Officer to pursue other opportunities, each effective March 6, 2025. The Company has also retained the services of an executive recruitment firm to commence a search for a new chief financial officer prepared to make strategic contributions to the Company. Mr. Blust age 48, has over 20 years of accounting and finance experience. Prior to joining the Company in September 2018, Mr. Blust served as the Controller at Vector Solutions. Mr. Blust also served as CFO for Honeycomb Company of America, and as Assistant Controller for Marinemax. He began his career in public accounting in 2004, serving with both Cherry Bekaert as well as Bobbitt, Pittinger & Company. Mr. Getman's departure is not based on any disagreement with the Company regarding accounting principles, practices or financial statement disclosures. Announcement • Feb 28
Trulieve Cannabis Corp. Appoints Jason Pernell as President Trulieve Cannabis Corp. announced the appointment of Jason Pernell as President, effective immediately. Mr. Pernell has over 20 years' experience as an entrepreneur and cannabis operator, co-founding Trulieve alongside Chairman and Chief Executive Officer Kim Rivers in 2015. Announcement • Feb 05
Trulieve Cannabis Corp. to Report Q4, 2024 Results on Feb 27, 2025 Trulieve Cannabis Corp. announced that they will report Q4, 2024 results on Feb 27, 2025 Announcement • Jan 25
Trulieve Cannabis Corp. Announces Relocation of Affiliated Dispensary to Lancaster, Pennsylvania Trulieve Cannabis Corp. announced the relocation of a Trulieve-affiliated medical marijuana dispensary to Lancaster, Pennsylvania. The new Lancaster location at 1603 Manheim Pike #1651 will host a grand opening celebration starting at 9 a.m. on January 31, with a ribbon cutting, partner giveaways, special discounts and more. Trulieve Lancaster will be open 9 a.m. - 8 p.m. Monday through Saturday and 10 a.m. - 6 p.m. on Sundays. Announcement • Oct 14
Trulieve Cannabis Corp. to Report Q3, 2024 Results on Nov 05, 2024 Trulieve Cannabis Corp. announced that they will report Q3, 2024 results on Nov 05, 2024 Announcement • Sep 05
Trulieve Opens Relocated Dispensary in Tucson, Arizona Trulieve Cannabis Corp. announced the relocation of a dispensary in Tucson, Arizona. The new Menlo Park location at 1010 S Freeway #130 will host a grand opening celebration starting at 8 a.m. September 13, with partner giveaways, DJs, special discounts and more. The new Trulieve Tucson Menlo Park will be open 7 a.m. – 10 p.m. seven days a week, carrying a wide variety of Trulieve in-house brands including Alchemy, Avenue, Co2lors, Loveli, Modern Flower, Muse, and Roll One, as well as a broad assortment of products from popular partner brands. Trulieve Arizona operates dispensaries in Apache Junction, Avondale, Casa Grande, Chandler, Cottonwood, Glendale, Guadalupe, Mesa, Peoria, Phoenix, Scottsdale, Sierra Vista, Tempe, and Tucson. Announcement • Jul 31
Trulieve Cannabis Corp. Launches #YesOn3 Product Line to Support Adult Use Campaign in Florida Trulieve Cannabis Corp. announced the launch of a new specialty product line supporting the ballot initiative to legalize adult cannabis use in Florida. The initial offerings will be available beginning Tuesday, July 30, with the first in a series of product releases and specials leading up to Election Day on Tuesday, November 5. Trulieve's proceeds from #YesOn3 specialty products may be used to support Amendment 3. All specialty products support Amendment 3 feature one of two new cannabis strains. The first strain, "Yo3" is a collaboration between Trulieve and Sunshine Cannabis. The second strain, named "Yon3" is a Trulieve-specific strain. #YesOn3 products will include pre-rolls, flower, gummies, and vape cartridges. Announcement • Jul 10
Trulieve Cannabis Corp. to Report Q2, 2024 Results on Aug 06, 2024 Trulieve Cannabis Corp. announced that they will report Q2, 2024 results on Aug 06, 2024 Announcement • Apr 06
Trulieve Cannabis Corp. to Report Q1, 2024 Results on May 09, 2024 Trulieve Cannabis Corp. announced that they will report Q1, 2024 results Pre-Market on May 09, 2024 Announcement • Mar 30
Trulieve Cannabis Corp., Annual General Meeting, Jun 12, 2024 Trulieve Cannabis Corp., Annual General Meeting, Jun 12, 2024. Announcement • Feb 06
Trulieve Cannabis Corp. to Report Q4, 2023 Results on Feb 29, 2024 Trulieve Cannabis Corp. announced that they will report Q4, 2023 results on Feb 29, 2024 Announcement • Jan 12
Trulieve Announces Appointment of Marie Zhang as Chief Operating Officer, Effective January 29, 2024 Trulieve Cannabis Corp. announced the appointment of Marie Zhang as Chief Operating Officer, effective January 29, 2024. Ms. Zhang has over 25 years' experience in operational roles for private and public companies including Blaze Pizza, Focus Brands, Yum! Brands, and ConAgra Foods. Announcement • Dec 23
Trulieve Cannabis Corp. Announces Chief Financial Officer Changes Trulieve Cannabis Corp. announced the appointment of Wes Getman as Chief Financial Officer, effective January 1, 2024. Mr. Getman has over 25 years' experience in accounting and finance in both corporate and advisory roles for private and public companies including Blue Bird Corporation, Grant Thornton, and PricewaterhouseCoopers. Ryan Blust was serving as Interim Chief Financial Officer. Mr. Blust will resume his duties as Vice President, Finance, once Wes Getman assumes the CFO role. Prior to joining the Company, Mr. Getman served as Partner, Advisory at WilliamsMarston, LLC. Mr. Getman previously served as the Vice President of Accounting & Finance at Blue Bird Corporation, a billion dollar North American manufacturer, from 2015-2020. In addition, Mr. Getman spent 16 years in public accounting at PwC, RSM, and Grant Thornton where he was a partner at the last two firms. Mr. Getman received his Bachelor of Science in Management from the State University of New York at Geneseo and his MBA from the Simon School at the University of Rochester. Announcement • Oct 21
Trulieve Cannabis Corp. to Report Q3, 2023 Results on Nov 09, 2023 Trulieve Cannabis Corp. announced that they will report Q3, 2023 results on Nov 09, 2023 Announcement • Oct 14
Trulieve Cannabis Corp. Announces Relocation of Medical Cannabis Dispensary in Melbourne, Florida Trulieve Cannabis Corp. announced the relocation of a medical cannabis dispensary in Melbourne, Florida. The new location at 1921 Alma Drive, less than one mile from Interstate 95, offers greater convenience to patients in southern Brevard County. Trulieve will host a grand opening celebration at the new location beginning at 9 a.m., Friday, October 20, with partner giveaways, music, specials, discounts, and opportunities to register for upcoming patient education sessions. The new Melbourne location will be open 9 a.m. - 8:30 p.m. Monday through Saturday and 11 a.m. - 8 p.m. on Sundays. Trulieve offers statewide home delivery, convenient online ordering, and in-store pickup. Veterans receive 20% off every order when they show their military ID, and all first-time guests are eligible for a 60% new customer discount at any Florida Trulieve location. Designed to meet every customer's needs, Trulieve's portfolio of popular in-house brands includes Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk and Trekkers. Customers also have access to beloved partner brands such as Alien Labs, Binske, Black Tuna, Blue River, Connected Cannabis, DeLisioso, Khalifa Kush, Love's Oven, Miami Mango, O.pen, Seed Junky and Sunshine Cannabis, all available exclusively at Trulieve in Florida. Announcement • Oct 05
Trulieve Cannabis Corp. Announces Stepping Down of Steve White as President Trulieve Cannabis Corp. announced Steve White is stepping down as the company's president, effective as of October 1, 2023. Mr. White will continue to serve as a strategic advisor to the company until his anticipated retirement at the end of 2023. Mr. White co-founded Harvest Health & Recreation (Harvest) in 2011 and served as its Chief Executive Officer until the acquisition of the company by Trulieve. As an early pioneer in the U.S. legal cannabis industry, Mr. White led Harvest as it grew from a single dispensary to become one of the top multi-state operators with cultivation, manufacturing, and retail operations in several markets. Following the Harvest acquisition, Mr. White was appointed President of the company. Announcement • Aug 01
Trulieve Cannabis Corp. Announces the Relocation of Medical Dispensary in Kissimmee, Florida Trulieve Cannabis Corp. announced the relocation of a medical dispensary in Kissimmee, Fla. Located at 2647 E. Irlo Bronson Memorial Hwy. Thedispensary will be open 9 AM - 8:30 PM Monday through Saturday and 11 AM - 8 PM on Sunday. Trulieve also offers statewide home delivery, convenient online ordering and in-store pickup. As always, all first- time guests are eligible for a 50% new customer discount at any Florida-based location. Designed to meet every patient's needs, portfolio of in-house brands includes Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk and Trekkers. Customers also have access to beloved brands such as Alien Labs, Bhang, Binske, Black Tuna, Blue River, ConnectedCannabis, DeLisioso, Khalifa Kush, Love's Oven, Miami Mango, Old Hippie Stash, O.Pen, Seed Junky and Sunshine Cannabis, all available exclusively at Trulieve in Florida. Announcement • Jul 23
Trulieve Cannabis Corp. Announces CFO Changes Trulieve Cannabis Corp. announced the appointment of Ryan Blust, the Company's Vice President, Finance, as its interim Chief Financial Officer and the departure of Tim Mullany as Chief Financial Officer for personal reasons, each effective July 20, 2023. The Company has also retained the services of an executive recruitment firm to commence a search for a new chief financial officer. Mr. Blust has over 18 years of accounting and finance experience. He joined Trulieve in September 2018, and has previously served as interim CFO for the Company. Prior to joining the Company, Mr. Blust served as the Controller at Vector Solutions, a software company. Mr. Blust also served as CFO for Honeycomb Company of America, an aerospace manufacturer, and as Assistant Controller for Marinemax, a retail boat company. He began his career in public accounting in 2004, serving with both Cherry Bekaert as well as Bobbitt, Pittinger & Company. Announcement • Jul 14
Trulieve Cannabis Corp. to Report Q2, 2023 Results on Aug 09, 2023 Trulieve Cannabis Corp. announced that they will report Q2, 2023 results on Aug 09, 2023 Announcement • Jun 20
Trulieve Cannabis Corp. Announces Appointment of Tim Mullany as Chief Financial Officer Trulieve Cannabis Corp. announced the appointment of Tim Mullany as Chief Financial Officer, effective July 10, 2023. Mr. Mullany has over 20 years' experience in accounting and finance including prior Chief Financial Officer roles at publicly traded companies Jack in the Box Inc. and RAVE Restaurant Group. The Company has accepted the resignation with immediate effect of Alex D'Amico, the Company's Chief Financial Officer, and has appointed Ryan Blust, the Company's Vice President, Finance, as its interim Chief Financial Officer, effective immediately, to serve until Tim Mullany assumes the role. Mr. Blust has over 18 years accounting and finance experience. He joined Trulieve in September 2018, and has previously served as interim CFO for the Company. Prior to joining the Company, Mr. Blust served as the Controller at Vector Solutions, a software company. Mr. Blust also served as CFO for Honeycomb Company of America, an aerospace manufacturer, and as Assistant Controller for Marinemax, a retail boat company. He began his career in public accounting in 2004, serving with both Cherry Bekaert as well as Bobbitt, Pittinger & Company. Announcement • Jun 02
Trulieve Continues Optimization Efforts with Closure of California Retail Location and Plan to Wind Down Massachusetts Operations Trulieve Cannabis Corp. announced additional measures to preserve cash and improve financial performance. Since mid-2022, Trulieve has undertaken proactive steps to rationalize cash and margin dilutive assets and streamline operations while reallocating resources toward attractive markets with long-term growth potential. Measures taken to date include the closure of select California retail assets, exit of the Nevada wholesale market and idling of production capacity to match consumer demand across multiple markets. Consistent with optimization efforts, Trulieve has elected to close the retail location in Grover Beach, California. This closure follows the exit of select California retail assets last year in Palm Springs and Venice. In addition, the Company has decided to wind down its operations in Massachusetts. Dispensaries located in Framingham, Northampton and Worcester will close on June 30, 2023. The Company expects to cease Massachusetts operations by the end of 2023. Trulieve continues to evaluate the performance of assets and markets within the current macroeconomic environment and will take additional steps as needed to optimize the business. The Company is focused on cash preservation and cash generation while continuing to make targeted investments in retail expansion as well as advanced data and technology platforms to set the foundation for a future defined by integrated commerce. Announcement • May 04
Joy Malivuk Appoints as the Vice President, Chief Accounting Officer of Trulieve Cannabis Corp On April 26, 2023, Joy Malivuk, age 48, was appointed as the Vice President, Chief Accounting Officer of Trulieve Cannabis Corp. Ms. Malivuk has nearly 24 years of accounting and finance experience. Prior to joining the Company, from 2008 to 2023, Ms. Malivuk held roles of increasing responsibility, including most recently as Director of Accounting at HSN Inc., a subsidiary of QVC Inc., where she oversaw the accounting function and was responsible for financial reporting, general accounting and SOX compliance. Previously, she served as HSN’s Operational Vice President of Financial Reporting and SEC Compliance. Her career began at PricewaterhouseCoopers, LLP. Ms. Malivuk graduated from the University of Florida with both a Bachelor of Science in Accounting and a Master of Accounting with a Specialty in Taxation. Announcement • Feb 18
Trulieve Cannabis Corp. Announces to Begin Adult-Use Cannabis Sales At Relocated Bristol, CT Dispensary Trulieve Cannabis Corp. announced its dispensary in Bristol, Connecticut will begin selling adult-use cannabis products on February 17 at 10 a.m. Recently relocated to 820 Farmington Ave., the Company's hybrid (medical and adult-use) dispensary will have operating hours of 9 a.m. - 8 p.m, with the first hour of each day reserved for medical-only sales. The adult-use launch ribbon-cutting event will be held on February 17 at 10 a.m. The spacious new showroom and ample parking at the new location enhance the overall customer experience. Announcement • Jan 21
Trulieve Cannabis Corp. Launches Highsman Cannabis Products from NFL Legend Ricky Williams in Arizona Trulieve Cannabis Corp. announced the official launch of Highsman, the purpose-driven cannabis lifestyle brand founded by NFL legend Ricky Williams. Highsman will be available statewide in all Trulieve and Harvest branded Arizona retail locations starting January 20, 2023. Highsman will be exclusively available at Trulieve and Harvest branded Arizona retail locations until February 4, 2023. Highsman has partnered with Abundant Organics to bring premium organically grown cannabis to Trulieve and Harvest's Arizona locations. Personally curated by Williams, the product selection includes eighths and pre-rolls. Announcement • Jan 14
Trulieve Cannabis Corp. Announces Resignation of Rebecca L. Young as Chief Accounting Officer Trulieve Cannabis Corp. announced, Rebecca L. Young, Vice President, Chief Accounting Officer of the Company, gave notice of her resignation to be effective as of March 10, 2023 in order to pursue other opportunities. Ms. Young will continue to serve in her role as Vice President, Chief Accounting Officer of the Company through March 10, 2023 in order to allow time to transition her responsibilities to Ms. Malivuk. Announcement • Sep 14
Trulieve Cannabis Corp. Debuts New Line of Concentrates Using Hydrocarbon Extraction Trulieve Cannabis Corp. announced the launch of a new line of high-quality cannabis concentrates made through hydrocarbon extraction. Live Resin, a high-terpene, single-source extract, is the first offering from Trulieve's new hydrocarbon line. Live Resin is created in Trulieve's hydrocarbon extraction lab using the company's proprietary blend of propane and butane on TruFlower that has been frozen immediately after harvest. The result is a strain-specific and full-spectrum concentrate that is exceptionally flavorful. It contains higher levels of cannabinoids and terpenes than other concentrates. Live Resin provides patients with a powerful and richly aromatic experience with a broader sensation of effects. Hydrocarbon extraction uses solvents to gently process cannabis, allowing for the retention of high levels of the plant's original flavor and terpene and cannabinoid profiles at a lower temperature. By protecting the delicate properties of the plant from high heat, the process creates a consumption experience most similar to smoking whole flower cannabis. Trulieve's first hydrocarbon extracted concentrates, Live Resin in the popular Member Berry and Orchard Nectar strains, are available in .5g sizes throughout Florida. All of the extracts in Trulieve's product line will be strain-specific, ranging across Indica, Sativa, and Hybrid products. Announcement • Sep 04
An unknown buyer acquired Ten Trulieve Cannabis Locations in Floridan from Trulieve Cannabis Corp. (CNSX:TRUL) for $14.8 million. An unknown buyer acquired Ten Trulieve Cannabis Locations in Floridan from Trulieve Cannabis Corp. (CNSX:TRUL) for $14.8 million recently. The local Trulieve Cannabis location at 6259 Beach Blvd. sold along with nine others in major Florida markets for $14.8 million. Announcement • Aug 20
Trulieve Becomes First MSO to Launch Clone Sales in Massachusetts Trulieve Cannabis Corp. announced it has successfully launched a pilot program selling its premium-quality cannabis clones at its Northampton, MA dispensary, in accordance with state law. This marks a significant first-to-market entry for the Company, where it is now the only multi state operator (MSO) to provide home growers with its products in the form of consistent, healthy, top-tier plants. Trulieve is releasing a limited amount of its Chocolope NewBerrySativa strain, which can be ordered online through the Company's Northampton location website and will be available for in-store pickup at 216 North King Street, Northampton, MA beginning August 20. Clones will be sold in packs of three and sales limited to one per customer during the initial launch phase. In the future, the Company plans to offer different strains based on consumer feedback and will expand clone availability across its Massachusetts locations. For citizens of Massachusetts interested in home grow, the launch of Trulieve's clone program represents a new opportunity to access the highest-quality genetics in a ready-to-grow format and ensures clone consistency and quality not previously available in the state. Cannabis clones carry the exact same genetic potential as their mother plant and will have similar cannabinoid and terpene profiles when grown properly. When clones are selected from healthy, high-quality mother plants, they also inherit their vigor, and natural resistance to mold, mildew, and pests. Announcement • Aug 06
Trulieve Introduces New Brand Portfolio Designed to Serve Consumers in Adult-Use and Medical Markets Trulieve Cannabis Corp. announced the launch of a comprehensive brand portfolio that includes four distinct brands designed to meet the needs of all consumers, from the canna-curious to the canna-connoisseur. With the addition of the Muse™, Sweet Talk™ and Momenta™ brands and the expansion of the Cultivar Collection™, the company is providing a range of high-quality, innovative, proprietary brands that together meet the full spectrum of consumer motivations and need-states. Trulieve's evolving house of brands highlights the opportunity for all consumers to "live their best life" via carefully curated products that cultivate the unique potential in all of us. The full Cultivar Collection including Muse, Momenta, and Sweet Talk will be available in the Massachusetts market, where the new brands have been introduced at the company's Northampton location. The Cultivar Collection launched in Florida in October 2020, and is one of Trulieve's fastest selling products. Pending regulatory approvals, the full suite of brands will be available in Trulieve's additional operating markets in the coming months. Announcement • Jun 11
Trulieve Cannabis Corp. Launches New Innovative Product: Refined Crème Trulieve Cannabis Corp. ("Trulieve") announced Refined Crème, a new high-end cannabis concentrate that blends cannabis-derived terpenes to offer patients a unique, elevated level of relief.
Refined Crème is a handcrafted concentrate developed using a cold ethanol extraction method and a careful hand-whipping technique over low heat. The result is an aromatic, creamy, batter-like concentrate that retains the flavor, cannabinoids, terpenes, and the resulting effects from the strain from which it is derived. Refined Crème will be available in Trulieve dispensaries across Florida starting June 10, 2021, in select Hybrid, Sativa, and Indica strains and will be available in one-gram quantities. Announcement • Jun 10
Trulieve Cannabis Corp. (CNSX:TRUL) completed the acquisition of Solevo Wellness West Virginia LLC. Trulieve Cannabis Corp. (CNSX:TRUL) agreed to acquire Solevo Wellness West Virginia LLC for $0.65 million on April 13, 2021. Trulieve has agreed to acquire Solevo and its three dispensary permits for $0.65 million with an upfront payment of $0.15 million in cash, and $0.5 million in Trulieve subordinate voting shares. The transaction is contingent upon regulatory approval by the state of West Virginia and customary closing conditions. Sean P. Coyle and Joshua Ashby of Fox Rothschild LLP are acting as legal counsel to Trulieve.
Trulieve Cannabis Corp. (CNSX:TRUL) completed the acquisition of Solevo Wellness West Virginia LLC on June 9, 2021. Announcement • May 12
Trulieve Cannabis Corp. (CNSX:TRUL) entered into a definitive agreement to acquire Harvest Health & Recreation Inc. (CNSX:HARV) for $1.2 billion. Trulieve Cannabis Corp. (CNSX:TRUL) entered into a definitive agreement to acquire Harvest Health & Recreation Inc. (CNSX:HARV) for $1.2 billion on May 10, 2021. Under the terms of the transaction, shareholders of Harvest will receive 0.1170 of a subordinate voting share of Trulieve for each Harvest subordinate voting share. After giving effect to the Transaction, Harvest Shareholders will hold approximately 26.7% of the issued and outstanding pro forma Trulieve Shares. In case of termination, the agreement provides a $100 million reciprocal termination fees under certain circumstances.
The Transaction is subject to, among other things, the approval of the necessary approvals of the Supreme Court of British Columbia, the approval of two-thirds of the votes cast by Harvest Shareholders at the Special Meeting, receipt of the required regulatory approvals, including, but not limited, approval pursuant to the Hart–Scott–Rodino Antitrust Improvements Act, and other customary conditions of closing. Approval of Trulieve Shareholders is not required. The Transaction has been unanimously approved by the Boards of Directors of each of Trulieve and Harvest. Harvest Shareholders holding more than 50% of the voting power of the issued and outstanding Harvest Shares have entered into voting support agreements with Trulieve to vote in favor of the Transaction. The transaction will be accretive to Trulieve shareholders. Canaccord Genuity Corp. acted as exclusive financial advisor and DLA Piper (Canada) LLP and Fox Rothschild LLP acted as Canadian and United States legal counsel, respectively, to Trulieve. Canaccord Genuity Corp. also provided a fairness opinion to the Board of Directors of Trulieve. Moelis & Company LLC acted as financial advisor and Bennett Jones LLP and Troutman Pepper LLP acted as Canadian and United States legal counsel, respectively, to Harvest. Haywood Securities Inc. provided a fairness opinion to the special committee of Harvest. Announcement • May 07
Trulieve Cannabis Corp. (CNSX:TRUL) completed the acquisition of Mountaineer Holding LLC. Trulieve Cannabis Corp. (CNSX:TRUL) has agreed to acquire Mountaineer Holding LLC for $6 million on March 22, 2021. The consideration comprised of $3 million in cash and $3 million in Trulieve's subordinate voting shares. The transaction is subject to customary closing conditions and regulatory approvals. The Mountaineer Holdings LLC deal has been unanimously approved by the board of directors of Trulieve. The deal is expected to close during the second quarter of 2021. Fox Rothschild LLP acted as a legal advisor to Trulieve Cannabis Corp.
Trulieve Cannabis Corp. (CNSX:TRUL) completed the acquisition of Mountaineer Holding LLC on May 6, 2021. Total transaction consideration was $6 million satisfied through the payment of $3 million in cash and by the issuance of 60,342 subordinate voting shares of Trulieve. Quarter Coast Consulting acted as strategic advisors and Bailey & Glasser LLP acted as legal advisor to Mountaineer Holding LLC. Announcement • Mar 24
Trulieve Cannabis Corp. Provides Earnings Guidance for the Full Year 2021 Trulieve Cannabis Corp. provided earnings guidance for the full year 2021. The company estimates 2021 revenues in the range of $815 million to $850 million. Announcement • Mar 17
Trulieve Cannabis Corp Announces Executive Changes Trulieve Cannabis Corp. announced the promotion of Eric Powers to Chief Legal Officer, and the appointments of Ronda Sheffield to Chief Human Resources Officer, Zachary Kobrin to General Counsel, and Aaron Lopez to Director Government Affairs effective March 15, 2021. Building out Trulieve's legal and human resources infrastructure and government affairs practice empowers the Company to meet growth more effectively. For the last two years, Eric Powers has served as Trulieve's General Counsel and Corporate Secretary, leading the legal team and supporting Trulieve's national expansion. As CLO, Powers will focus strategically on Trulieve's shift to national expansion. He has more than 25 years of broad legal experience through his work in corporate and tax law, both in-house and private practice. Most recently the Chief Human Resources Officer for ModWash, Sheffield has held HR leadership positions for top corporations including Lowe's Home Improvement, Sprint Wireless, Starbucks Coffee Company, and Walmart Stores—where she led the HR functions for both the corporate and retail divisions. Zack Kobrin was a partner with Akerman LLP, where he was a leader in the firm's nationally recognized cannabis practice group. Prior to Akerman, Zack was the General Counsel and Chief Compliance Officer for a multi-state cannabis company and is considered an expert in cannabis and hemp law matters. Aaron Lopez joins as Trulieve's first Director of Government Affairs. Prior to joining Trulieve, Lopez was the founder of Political Capital LLC, which has worked with leading clients in multiple industries to provide insight and a voice in the legislative and political processes at international, federal, and state levels. Announcement • Mar 11
Trulieve and Morehouse School of Medicine Partner for Cannabis Research and Education Trulieve Cannabis Corp. announced that it has partnered with Morehouse School of Medicine to fund and conduct medical cannabis research and education. Trulieve and the Morehouse School of Medicine have entered into a mutually agreeable collaborative research, education, and development agreement where Trulieve Georgia will support Morehouse School of Medicine medical cannabis-related research and development projects, and provide course education opportunities and resources. Among the first of its kind in the United States and as one of Trulieve's core long-term objectives, this partnership will represent one of the initial steps toward the development of personalized medical cannabis treatment. The partnership will aim to further research and develop a real-world data registry on medical cannabis, including the exploration of cannabinoid receptor genetics, as well as research into the effects and unrealized potential of medical cannabis usage, and endocannabinoid biology. Trulieve and Morehouse School of Medicine plan to partner with TruGenomix Inc., a veteran-owned small business, founded and led by minorities, for gene sequencing services. Announcement • Feb 25
Trulieve Cannabis Corp. to Report Q4, 2020 Results on Mar 23, 2021 Trulieve Cannabis Corp. announced that they will report Q4, 2020 results Pre-Market on Mar 23, 2021 Announcement • Feb 04
Trulieve Cannabis Corp. Announces Expansion of its Blue RiverTM Extracts Lineup with Cold Cure Live Rosin Trulieve Cannabis Corp. (‘Trulieve’) announced the expansion of its Blue RiverTM extracts lineup with Cold Cure Live Rosin. This newest addition to the Blue River products sold in Trulieve stores across Florida will be its most premium concentrate offering to date. Cold Cure Live Rosin is a solventless extract offering a balanced experience between flavor, effect, and potency with extreme purity. Blue River's Cold Cure Live Rosin uses only Trulieve's premium quality flower. Using live cannabis harvesting practices and ice water extraction methods preserves a higher concentration of the naturally occurring terpenes resulting in an extract that offers a premium grade of rosin with a higher concentration of flavor, broader range of effects, and overall better consistency. Announcement • Nov 19
Trulieve Cannabis Corp. Launches TruSpectrum, Bringing the Future of Cannabis to Florida Trulieve Cannabis Corp. announced the launch of a new product TruSpectrum. Trulieve's TruSpectrum is a new class of product that provides whole-plant, full-spectrum relief made without additives or additional ingredients, in an oil-based, vaporizable format. Trulieve TruSpectrum, a whole-plant extract product, contains cannabis-derived terpenes that are retained throughout the extraction process. The cannabinoids and terpenes come from a single strain of high-quality cannabis without any reintroductions resulting in a powerful, flavorful, and effective full-spectrum oil. TruSpectrum will be available in a portable, discrete vaporizer cartridge in Indica, Sativa, and Hybrid strains. TruSpectrum launches in a half-gram TruPOD cartridge with plans to expand in the coming months. Patients will be able to purchase TruSpectrum at any of Trulieve's 67 dispensaries across the state of Florida. Announcement • Nov 14
Trulieve Selected and Approves as Medical Cannabis Licensee in West Virginia, Enters 6Th State Trulieve Cannabis Corp. announced that it has been awarded a processor permit by the West Virginia Office of Medical Cannabis. The selection now gives the multi-state operator a presence in six states. Trulieve is committed to investing in the communities it operates in and will further this commitment by working with well-regarded local businesses during construction and operation. Trulieve expects to be operational in the state within the next six months. Announcement • Oct 18
Trulieve Cannabis Corp. Announces the Launch of the Cultivar Collection by Trulieve, A Line of High-Quality, Small-Batch Cultivar Strains Trulieve Cannabis Corp. announced the launch of the Cultivar Collection by Trulieve, a line of high-quality, small-batch cultivar strains. Curated by Trulieve's own master growers, the Cultivar Collection features exclusive strains with unique, premium flavor and terpene profiles. The Cultivar Collection and will be available at select Trulieve stores starting on October 17, 2020. Each cultivar is grown in rooms specifically designed for small-batch cultivation. Led by Trulieve's master growers, all strains in the Cultivar Collection are individually managed by hand each step of the way, creating a unique harvest. The Cultivar Collection by Trulieve will launch with three exclusive strains: Grape Cake, Sunset Sherbet x Kush Mints, and Rae Bae. The product line will be available in 3.5 gram options. The Cultivar Collection, with new strains continuously launching, will be available at select stores across Florida. Announcement • Oct 14
Trulieve Cannabis Corp. to Report Q3, 2020 Results on Nov 17, 2020 Trulieve Cannabis Corp. announced that they will report Q3, 2020 results at 9:00 AM, Eastern Standard Time on Nov 17, 2020 Announcement • Sep 26
Trulieve Cannabis Corp. (CNSX:TRUL) entered into definitive agreement to acquire PurePenn, LLC and Pioneer Leasing & Consulting LLC for approximately $110 million. Trulieve Cannabis Corp. (CNSX:TRUL) entered into definitive agreement to acquire PurePenn, LLC and Pioneer Leasing & Consulting LLC for approximately $110 million on September 16, 2020. Trulieve will pay an upfront payment of $46 million, comprised of $27 million in Trulieve subordinate voting shares and $19 million in cash, plus a potential earn-out payment of up to approximately $60 million in Trulieve subordinate voting shares based on the achievement of certain agreed EBITDA milestones. In a related transaction, Trulieve Cannabis entered into definitive agreement to acquire Keystone Relief Centers LLC for $35 million. The Transaction is subject to customary closing conditions and regulatory approvals and is expected to close during the fourth quarter of 2020. This is an accretive transaction on an EBITDA basis. Canaccord Genuity Corp. is acting as the financial advisor and Zachary R. Kobrin and Sean Patrick Coyle of Akerman LLP acted as legal counsel to Trulieve Cannabis Corp. Saul Ewing Arnstein & Lehr LLC is acting as legal counsel to PurePenn, LLC and Pioneer Leasing & Consulting LLC. Announcement • Sep 22
Trulieve Cannabis Corp. has completed a Follow-on Equity Offering in the amount of CAD 100.45 million. Trulieve Cannabis Corp. has completed a Follow-on Equity Offering in the amount of CAD 100.45 million.
Security Name: Subordinate Voting Shares
Security Type: Common Stock
Securities Offered: 4,100,000
Price\Range: CAD 24.5
Discount Per Security: CAD 1.1025 Announcement • Jul 10
Trulieve Cannabis Corp. to Report Q2, 2020 Results on Aug 12, 2020 Trulieve Cannabis Corp. announced that they will report Q2, 2020 results at 9:00 AM, Eastern Standard Time on Aug 12, 2020 
